These conflicting views on the role of METTL3—whether it promotes or suppresses glioma—may be attributed to the diverse target genes affected by m6A and the heterogeneity of tumor stem cells, both genetically and non-genetically (Fig. 3). Here, METTL3 is linked to central nervous system cancer.